Kamel Hadj‐Kaddour

Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microti†

Emmanuel Cornillot, Kamel Hadj‐Kaddour, Amina Dassouli et al. · Nucleic Acids Research · 2012 · 219 citations · Full text

Life Sciences, Biology, Microbiology +17

New imidazoquinoxaline derivatives: Synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure–activity relationships

Zahraa Zghaib, Jean‐François Guichou, Johanna Vappiani et al. · Bioorganic & Medicinal Chemistry · 2016 · 34 citations

Medicine, Medicinal Chemistry, Oncology +16

Hydrophobic moeties in recombinant proteins are crucial to generate efficient saponin-based vaccine against Apicomplexan Babesia divergens

Stéphane Delbecq, Kamel Hadj‐Kaddour, Sylvie Randazzo et al. · Vaccine · 2005 · 33 citations

Pharmacy, Biotechnology, Immunology +17

Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and Pyrazolo[1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors

Cindy Patinote, Nour Bou Karroum, Georges Moarbess et al. · European Journal of Medicinal Chemistry · 2017 · 30 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

Recombinant protein Bd37 protected gerbils against heterologous challenges with isolates of<i>Babesia divergens</i>polymorphic for the<i>bd37</i>gene

Kamel Hadj‐Kaddour, B. Carcy, Améline Vallet et al. · Parasitology · 2006 · 29 citations

Life Sciences, Genetics, Immunology +15